Filing Details
- Accession Number:
- 0001209191-22-013791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-28 19:13:32
- Reporting Period:
- 2022-02-24
- Accepted Time:
- 2022-02-28 19:13:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1805890 | Fusion Pharmaceuticals Inc. | FUSN | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1813574 | John Valliant | C/O Fusion Pharmaceuticals, Inc. 2 International Place, Suite 2310 Boston MA 02110 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-02-24 | 2,500 | $7.41 | 443,635 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-02-25 | 8,152 | $7.57 | 435,483 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-02-28 | 3,100 | $7.40 | 432,383 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $7.32 to $7.50 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $7.39 to $7.83 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $7.21 to $7.67 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.